retatrutide clinical trial texas Retatrutide, Eli Lilly's next obesity shot, showed far more weight loss in patients than other blockbuster obesity drugs. MORE BELOW ⬇️ Retatrutide Phase 3: 60% Achieved
Description
These effects were consistent with the drugs triple agonist mechanism of action
The brand says their new pills promote healthy weight loss but what the hell does healthy weight loss even mean, especially when a reality TV starnot a doctor or nutritionist or medical expertis the one pushing the pills
Non-diabetic subjects who were on average 5 years post-RYGB and at a steady weight were administered a mixed meal
This makes peptides the obvious choice when mimicking receptor interactions
